Skip to main content
SpringerLink
Log in

Pathologie und neue UICC-Klassifikation des Ösophaguskarzinoms

Pathology and new UICC classification of esophageal carcinoma

Der Onkologe volume 16, pages 453–461 (2010)Cite this article

Zusammenfassung

Eine einheitliche klinische und pathologische Tumorklassifikation spielt für Karzinome des Ösophagus eine bedeutsame Rolle für Diagnostik, Therapie und Prognose. Die aktuelle 7. Auflage der International-Union-Against-Cancer- (UICC-)Klassifikation definiert unterschiedliche Stadien abhängig von der Ausbreitung des Primärtumors, dem Befall der regionären Lymphknoten und dem Vorhandensein von Fernmetastasen. Sie enthält auch eine Definition für Karzinome des ösophagogastralen Übergangs. Besondere Aufmerksamkeit verlangt die Anwendung von Tumorklassifikationen nach neoadjuvanter Therapie.

Abstract

A uniform use of tumor classifications by clinicians and pathologists alike plays an important role for esophageal carcinoma concerning diagnosis, therapy and prognosis. The current 7th edition of the International Union Against Cancer (UICC) classification defines different stages depending on the extent of the primary tumor, spread to regional lymph nodes and the presence or absence of distant metastases. It also contains a definition of adenocarcinoma of the esophagogastric junction. Application of tumor classifications after neoadjuvant therapy demands special attention.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Abb. 1
Abb. 2

Literatur

  1. AJCC (2009) AJCC Cancer Staging Manual In: Edge SB, Byrd DR, Compton CC et al (eds) 7th edn. Springer, New York

  2. Bollschweiler E, Baldus SE, Schröder W et al (2006) Staging of esophageal carcinoma: length of tumor and number of involved lymph nodes. Are these independent prognostic factors? J Surg Oncol 94:355–363

    Article  PubMed  Google Scholar 

  3. Bollschweiler E, Hölscher A (2004) Epidemiologie – Ösophaguskarzinom, Magenkarzinom. Management des Ösophagus- und Magenkarzinoms. In: Meyer HJ, Buhr HJ, Wilke H (Hrsg) Springer, Berlin Heidelberg New York, S 15–35

  4. Christie NA, Rice TW, DeCamp MM et al (1999) M1a/M1b esophageal carcinoma: clinical relevance. J Thorac Cardiovasc Surg 118:900–907

    Article  CAS  PubMed  Google Scholar 

  5. Ellis FH Jr, Heatley GJ, Balogh K (1997) Proposal for improved staging criteria for carcinoma of the esophagus and cardia. Eur J Cardiothorac Surg 12:361–365

    Article  PubMed  Google Scholar 

  6. Korst RJ, Rusch VW, Venkatraman E et al (1998) Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115:660–670

    Article  CAS  PubMed  Google Scholar 

  7. Hamilton SR, Aaltonen LA (eds) (2000) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive system. IARC Press, Lyon

  8. Hermann RM, Horstmann O, Haller F et al (2006) Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? Dis Esophagus 19:329–334

    Article  CAS  PubMed  Google Scholar 

  9. Ishwaran H, Blackstone EH, Apperson-Hansen C et al (2009) A novel approach to cancer staging: application to esophageal cancer. Biostatistics 10:603–620

    Article  PubMed  Google Scholar 

  10. Lagarde SM, ten Kate FJ, Reitsma JB et al (2006) Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 26:4347–4355

    Article  Google Scholar 

  11. National Cancer Institute (2009) SEER Cancer Statistics Review, 1975–2006. Cancer of the esophagus (invasive), Tab. 8.19 Case distribution by histology. http://seer.cancer.gov/csr/1975_2006/results_merged/sect_08_esophagus.pdf, Zugriff am 31.01.2010

  12. Neid M, Tannapfel A, Wittekind CH (2008) Gastrointestinale Tumoren. Histologisches Regressionsgrading nach neoadjuvanter Therapie. Onkologe 14:409–417

    Article  Google Scholar 

  13. Pedrazzani C, Manzoni G de, Marrelli D et al (2007) It is time for a proper staging system for adenoarcinoma of the gastroesophageal junction. J Clin Oncol 25:907–908; author reply 908–909

    Article  PubMed  Google Scholar 

  14. Rice TW, Blackstone EH, Rybicki LA et al (2003) Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125:1103–1113

    Article  PubMed  Google Scholar 

  15. Rusch VW, Ishwaran H, Blackstone EH (2010). Cancer of the esophagus and esophagogastric junction: Data-driven staging for the 7th edn of the AJCC cancer staging manual. Cancer (in press)

    Google Scholar 

  16. Schneider PM, Baldus SE, Metzger R et al (2005) Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 242:684–692

    Article  PubMed  Google Scholar 

  17. Sinn HP, Hermanek P, Wagner G, Wittekind CH (2003) Organspezifische Tumordokumentation. Empfehlungen zu Dokumentationsinhalten für Studien. 3. Aufl. Internetfassung („OTD-3-Internet“) Deutsche Krebsgesellschaft, Frankfurt/Main http://www.krebsgesellschaft.de.

  18. Thompson SK, Ruszkiewicz AR, Jamieson GG et al (2008) Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 15:3447–3458

    Article  PubMed  Google Scholar 

  19. UICC (2002) TNM Classification of Malignant Tumours In: Sobin LH, Wittekind CH (eds) 6th edn. Wiley & Sons, New York [In: Wittekind Ch, Meyer HJ, Bootz F (Hrsg) Deutsche Übersetzung: TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York]

  20. UICC (2003) TNM Supplement. A commentary on uniform use In: Wittekind CH, Greene FL, Henson DE et al (eds) 3rd edn. Wiley & Sons, New York

    Google Scholar 

  21. UICC (2009) TNM Classification of Malignant Tumours In: Sobin LH, Gospodarowicz MK, Wittekind CH (eds) 7th edn. Wiley-Blackwell, Oxford [(2010) Wittekind CH, Meyer HJ (Hrsg) Deutsche Übersetzung: TNM-Klassifikation maligner Tumoren, 7. Aufl. Wiley-Blackwell, Weinheim]

  22. Wijnhoven BP, Tran KT, Esterman A et al (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245:717–725

    Article  PubMed  Google Scholar 

  23. Wilson M, Rosato EL, Chojnacki KA et al (2008) Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res 146:11–15

    Article  PubMed  Google Scholar 

  24. Wittekind CH, Oberschmid B (2009) Nutzung von Tumorklassifikationen nach neoadjuvanter Therapie. Onkologe 15:1155–1166

    Article  Google Scholar 

  25. Wittekind CH, Tannapfel A (2004) Pathologische Morphologie und Prognosefaktoren– Ösophaguskarzinom, Magenkarzinom. In: Meyer HJ, Buhr HJ, Wilke H (Hrsg) Management des Ösophagus- und Magenkarzinoms. Springer, Berlin Heidelberg New York, S 81–92

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Institut für Pathologie, Universitätsklinikum, Liebigstraße 26, 04103, Leipzig, Deutschland

    C. Wittekind & B. Oberschmid

Authors
  1. C. Wittekind
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Oberschmid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Wittekind.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wittekind, C., Oberschmid, B. Pathologie und neue UICC-Klassifikation des Ösophaguskarzinoms. Onkologe 16, 453–461 (2010). https://doi.org/10.1007/s00761-010-1831-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-010-1831-9

Schlüsselwörter

Keywords

search

Navigation